Genome-wide expression profiling reveals transcriptomic variation and perturbed gene networks in androgen-dependent and androgen-independent prostate cancer cells.
about
P1343
Tumor Targeting and Drug Delivery by Anthrax ToxinCellular prostatic acid phosphatase, a PTEN-functional homologue in prostate epithelia, functions as a prostate-specific tumor suppressorDiscovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy"Topological significance" analysis of gene expression and proteomic profiles from prostate cancer cells reveals key mechanisms of androgen responsePRKC-ζ Expression Promotes the Aggressive Phenotype of Human Prostate Cancer Cells and Is a Novel Target for Therapeutic Intervention.Emerging Roles for SSeCKS/Gravin/AKAP12 in the Control of Cell Proliferation, Cancer Malignancy, and Barriergenesis.Over-expressed Testis-specific Protein Y-encoded 1 as a novel biomarker for male hepatocellular carcinoma.Copy number alterations in prostate tumors and disease aggressivenessGenetic Determinants of Metabolism and Benign Prostate Enlargement: Associations with Prostate Volume.Heteronemin Is a Novel c-Met/STAT3 Inhibitor Against Advanced Prostate Cancer Cells.Identifying New Candidate Genes and Chemicals Related to Prostate Cancer Using a Hybrid Network and Shortest Path Approach.Expression of SOCS1 and the downstream targets of its putative tumor suppressor functions in prostate cancer.Mechanistic Support for Combined MET and AR Blockade in Castration-Resistant Prostate Cancer.Integration of Metabolomics and Transcriptomics Reveals Major Metabolic Pathways and Potential Biomarker Involved in Prostate Cancer.Down-regulation of tumor endothelial marker 8 suppresses cell proliferation mediated by ERK1/2 activity.Modulation of protein phosphatase 2A activity alters androgen-independent growth of prostate cancer cells: therapeutic implicationsImpaired expression of protein phosphatase 2A subunits enhances metastatic potential of human prostate cancer cells through activation of AKT pathway.The tumor suppressor TERE1 (UBIAD1) prenyltransferase regulates the elevated cholesterol phenotype in castration resistant prostate cancer by controlling a program of ligand dependent SXR target genes.Suppression of tumor and metastasis progression through the scaffolding functions of SSeCKS/Gravin/AKAP12Expression of the Y-Encoded TSPY is Associated with Progression of Prostate Cancer.Transgenic Mouse Studies to Understand the Regulation, Expression and Function of the Testis-Specific Protein Y-Encoded (TSPY) Gene.The regulatory roles of phosphatases in cancer.EphA3 biology and cancer.All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase.PROTOCADHERIN 7 Acts through SET and PP2A to Potentiate MAPK Signaling by EGFR and KRAS during Lung Tumorigenesis.Overexpression of CXCL3 can enhance the oncogenic potential of prostate cancer.Restoration of PPP2CA expression reverses epithelial-to-mesenchymal transition and suppresses prostate tumour growth and metastasis in an orthotopic mouse model.Role of protein phosphatases in genitourinary cancers.Exploring the Wnt pathway-associated LncRNAs and genes involved in pancreatic carcinogenesis driven by Tp53 mutation.D-glucuronyl C5-epimerase cell type specifically affects angiogenesis pathway in different prostate cancer cells.PPP2R2C loss promotes castration-resistance and is associated with increased prostate cancer-specific mortality.Down-regulation of miR-200b-3p by low p73 contributes to the androgen-independence of prostate cancer cells.Identification of miR-30d as a novel prognostic maker of prostate cancer.AURKA suppression induces DU145 apoptosis and sensitizes DU145 to docetaxel treatment.Inactivation of AMPK alters gene expression and promotes growth of prostate cancer cells.Genetic variants in PPP2CA are associated with gastric cancer risk in a Chinese population.Deactivation of sphingosine kinase 1 by protein phosphatase 2A.Expression of SOCSs in human prostate cancer and their association in prognosis.Whole exome sequencing reveals intertumor heterogeneity and distinct genetic origins of sporadic synchronous colorectal cancer.Differential Expression Patterns of Eph Receptors and Ephrin Ligands in Human Cancers.
P2860
Q26744720-262551FC-6D05-4B88-8BFF-B1BF4FEBAC2FQ26863333-0EA6F960-FED1-44AA-94FD-1361CB96654AQ28534277-F6961722-3BA1-4E50-9BED-386297653B60Q28751755-F790B40A-0EA2-4FFF-A7E5-0416343160D9Q34972318-15781F89-64E7-4D66-89CF-EC689CE633D1Q34972774-ADDBA4FD-9191-41A3-BADA-42074D7634A2Q35106868-76D4F6F6-118D-4D60-8BD8-FED53481779CQ35531720-BBB7E928-2473-45D0-92C0-A49ECFB8C986Q35687087-DCE53C6C-CE61-454B-AE3C-7DFCDD02AEC3Q36077939-DEF27708-826B-418F-943E-D9642FB106D3Q36173081-95B92414-6CAB-41C0-BB76-AACF4090ADB8Q36290408-97C2521C-10AF-4C22-9F16-BA644BE9EDD7Q36527826-767209FF-910E-4A1B-83B3-9DF59524BD15Q36604092-DC8D7A96-72E0-4D1B-B89A-75F1AF2EBA7AQ36708900-FA1E4302-E9E5-4718-B935-D400810E44E9Q36892504-19555521-2854-43FA-9706-803E82AEDE6FQ36959063-BE81F7DA-8EDF-4CB0-8310-48513280C1C7Q37138526-2B645060-175A-4EBC-9E24-F5FD450F2897Q37537319-7F58B23F-EC3F-44CE-8200-9EF3EF6FFC74Q37637012-3276D930-952B-4E71-B75E-EEE71D1D1E28Q37637016-0028C9C1-3F80-4DD9-852D-8AC4163B6B39Q38090432-08447429-36F6-48A4-818E-B1F906356D8AQ38267753-99913664-A1C4-4192-B63F-32CF6EB87865Q38617799-24C6E0BE-2A54-4707-9EA9-C1FFE7A6C4FCQ38732488-AEBB18C0-1E01-4DBB-B40D-ED3162B6CB33Q38797305-7FB55324-4FAF-4F3F-ABB1-961C99FB21BAQ38838867-54717C27-43AF-47D7-ACDB-153878C59DD8Q38941676-FCCD33F6-F53A-4C68-AB43-3F71EF883C71Q39029846-FE333595-AE9F-4732-A074-7D05EE005036Q39058766-5A0C8583-E75E-42C8-A6DD-5096ACDE1DFEQ39181062-AC8F8E15-C2CC-435D-9B99-07F0495E4F72Q39198252-D1C204FE-EE16-4E8D-B283-D0D9D23029C8Q39227897-6EDCC7E8-169E-4F4E-A2FE-038CDC7025CEQ39427098-0940D1FF-DA9D-44CE-96C8-96CA0285D2DDQ39863992-29FA7704-287B-4AE3-B03F-7F445CF90ED7Q40042252-3BBA66EA-7F03-4D22-BDAB-8A029CE1C77AQ40456885-59DE2394-243A-4454-9B4D-A6D27E911F3DQ46742441-AF8BEE8F-0FD2-4412-A0D1-32A7C466331EQ48361292-88504C53-8CC2-4111-8DD4-67BD534E064DQ55286883-EA799C16-B632-4ABD-AA7C-F3DEFCEF75B5
P2860
Genome-wide expression profiling reveals transcriptomic variation and perturbed gene networks in androgen-dependent and androgen-independent prostate cancer cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 October 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Genome-wide expression profili ...... pendent prostate cancer cells.
@en
Genome-wide expression profili ...... pendent prostate cancer cells.
@nl
type
label
Genome-wide expression profili ...... pendent prostate cancer cells.
@en
Genome-wide expression profili ...... pendent prostate cancer cells.
@nl
prefLabel
Genome-wide expression profili ...... pendent prostate cancer cells.
@en
Genome-wide expression profili ...... pendent prostate cancer cells.
@nl
P2093
P2860
P1433
P1476
Genome-wide expression profili ...... ependent prostate cancer cells
@en
P2093
James D Eudy
Kunal Chaudhary
Lynette Smith
Ming-Fong Lin
Sangeeta Bafna
Sonny L Johansson
Surinder K Batra
P2860
P356
10.1016/J.CANLET.2007.09.018
P407
P4510
P577
2007-10-30T00:00:00Z